Detalhe da pesquisa
1.
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria.
Circulation
; 149(6): 450-462, 2024 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37952217
2.
Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.
Circulation
; 2024 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38583093
3.
Cardiorenal Biomarkers, Canagliflozin, and Outcomes in Diabetic Kidney Disease: The CREDENCE Trial.
Circulation
; 148(8): 651-660, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37603600
4.
Effect of Salt Substitution on Cardiovascular Events and Death.
N Engl J Med
; 385(12): 1067-1077, 2021 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34459569
5.
Natriuretic Peptides and Prognosis in Patients With Type 2 Diabetes Mellitus and High Risk for Cardiovascular Events.
J Card Fail
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38614444
6.
The potential for current sodium and potassium production to support a global switch to the use of potassium-enriched salt: a desktop research study.
Public Health Nutr
; 27(1): e125, 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38644629
7.
The impact of pharmacotherapy on sexual function in female patients being treated for idiopathic overactive bladder: a systematic review.
BMC Womens Health
; 24(1): 290, 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38755593
8.
Sodium-based paracetamol: impact on blood pressure, cardiovascular events, and all-cause mortality.
Eur Heart J
; 44(42): 4448-4457, 2023 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37611115
9.
Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials.
Circulation
; 145(19): 1460-1470, 2022 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35394821
10.
Cost-Effectiveness of a Household Salt Substitution Intervention: Findings From 20 995 Participants of the Salt Substitute and Stroke Study.
Circulation
; 145(20): 1534-1541, 2022 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35311346
11.
Sodium glucose co-transporter 2 inhibition increases epidermal growth factor expression and improves outcomes in patients with type 2 diabetes.
Kidney Int
; 104(4): 828-839, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37543256
12.
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial.
Am J Kidney Dis
; 82(1): 84-96.e1, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36889425
13.
The importance of targeting multiple risk markers in patients with type 2 diabetes: A post-hoc study from the CANVAS programme.
Diabetes Obes Metab
; 25(6): 1638-1645, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36782264
14.
Changes in sodium levels in Australian packaged foods between 2014 and 2019: an interrupted time series analysis of the impact of the Victorian Salt Reduction Partnership's media advocacy strategy.
Int J Behav Nutr Phys Act
; 20(1): 71, 2023 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37316889
15.
Outcomes of a state-wide salt reduction initiative in adults living in Victoria, Australia.
Eur J Nutr
; 62(7): 3055-3067, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37493681
16.
Evaluation of a state-wide intervention on salt intake in primary schoolchildren living in Victoria, Australia.
Public Health Nutr
; 26(7): 1456-1467, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36785876
17.
Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical Trial.
JAMA
; 329(14): 1160-1169, 2023 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37039792
18.
Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE Trial.
Circulation
; 143(18): 1735-1749, 2021 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33554616
19.
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial.
Lancet
; 398(10305): 1043-1052, 2021 09 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34469767
20.
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
N Engl J Med
; 380(24): 2295-2306, 2019 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30990260